veliparib misses pfs endpoint, advances to phase iii trial
Published 7 years ago • 59 plays • Length 4:22Download video MP4
Download video MP3
Similar videos
-
4:47
phase iii study of veliparib with carboplatin and paclitaxel in her2-negative advanced/metastati...
-
3:45
fire-3: cetuximab/folfiri prolongs metastatic colorectal cancer survival
-
4:19
asco: new treatment (t-dm1) for her2-positive advanced breast cancer?
-
3:07
breast cancer drug t-dm1 shows promise in trial
-
2:24
biomarker analysis of cobrim: phase 3 trial of cobimetinib plus vemurafenib for advanced melanoma
-
6:07
introduction to endpoints in oncology clinical trials
-
21:14
clinical interpretation and validity of clinical trials: when do they become practice changing?
-
17:25
was this cancer clinical trial unethical? | one doctor reflects on a recent controversy
-
3:43
pemetrexed
-
4:44
phases of cancer clinical trials – an introduction, with neal meropol, md
-
3:18
updated standardized definitions for efficacy end points in adjuvant breast cancer clinical trials
-
4:06
clinical data from the phase iii prima trial
-
4:01
melanoma advances make chemo third-tier therapy
-
2:38
regorafenib lengthens suvival in colorectal cancer with kras mutation
-
11:31
fda approves combo immunotherapy for mesothelioma, atezolizumab strikes out in ovarian cancer,...
-
1:46
combination of veliparib and chemotherapy in brca-positive breast cancer
-
0:28
the shorter study investigates the safety of #mri-guided #radiation for #prostatecancer!
-
0:59
clinical trials then vs clinical trials now. how are they different? #shorts #targetcancerpodcast
-
3:00
five ‘can’t miss’ oncologic emergencies
-
2:43
primary hyperaldosteronism | endocrinology | medstudy pediatrics core audio pearls
-
7:25
patients can read notes starting nov. 2; younger african americans may be missed by lung cancer...
-
9:51
clinical trial designs & esmo-mcbs